Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of Anti Dilutive Common Shares

v3.24.1
Summary of Significant Accounting Policies (Details) - Schedule of Anti Dilutive Common Shares - shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total potentially dilutive shares 1,001,261 189,393
Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total potentially dilutive shares 17,788 8,561
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total potentially dilutive shares 983,473 [1] 180,832
[1] Note that amount excludes 257,205 warrants that require holders to pay a nominal amount of consideration; such underlying shares are included in the weighted average outstanding shares calculation for the purposes of basic earnings per share as of December 31, 2023. As such, this number of warrants will differ from those disclosed in Note 7 by the same amount.